Skip to main content
. 2022 Oct 21;13:1015372. doi: 10.3389/fimmu.2022.1015372

Figure 2.

Figure 2

Fecal Lcn-2 is a biomarker for the development of spontaneous EAE in 3A6/DR2a mice. (A) Association between increase in fecal Lcn-2 levels (ng/mg total protein) and development of spontaneous EAE (Non-EAE; n = 62, EAE; n = 18).(B) Time course of development of spontaneous EAE (•) and fecal Lcn-2 levels (◼) in 3A6/DR2a Tg mice. Fecal Lcn-2 levels before and after clinical EAE onset are shown. Mean ± SEM (n =6). (C) Immunohistopathology showing increase in Lcn2+ Ly6G+ cells in the large intestine upon development of EAE. (D) Increase in neutrophil (Ly6G+) cells in the large intestine (LI) upon development of EAE. (E, F) Large intestines (E) and small intestine (F) were stained with anti-Lcn-2 mAb and anti-Ly6G mAb, and number of Lcn-2+(red), Ly6G+ (green), and Lcn-2+ Ly6G+ (yellow) cells were quantified. Mean ± SEM. *P < 0.05, ***P < 0.001.